BR-3003

N/A

Report date: 2024/11/04 16:56:59
NME

Base Information

Drug NameBR-3003
Drug Alias NameBR-3003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersPeroxisome proliferator-activated receptor γ agonistsSodium/glucose cotransporter 2 inhibitors
TargetsPeroxisome proliferator-activated receptor γSodium/glucose cotransporter 2
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoryung Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBoryung Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A